Related Experiment Video
Updated: Apr 21, 2026

Crystal Structure of the N-terminal Domain of Ryanodine Receptor from Plutella xylostella
Published on: November 30, 2018
Structural insights into the human RyR2 N-terminal region involved in cardiac arrhythmias
Lubomír Borko1, Vladena Bauerová-Hlinková1, Eva Hostinová1
1Department of Biochemistry and Structural Biology, Institute of Molecular Biology, Slovak Academy of Sciences, Dúbravská cesta 21, 845 51 Bratislava, Slovakia.
Abstract:
Human ryanodine receptor 2 (hRyR2) mediates calcium release from the sarcoplasmic reticulum, enabling cardiomyocyte contraction. The N-terminal region of hRyR2 (amino acids 1-606) is the target of >30 arrhythmogenic mutations and contains a binding site for phosphoprotein phosphatase 1. Here, the solution and crystal structures determined under near-physiological conditions, as well as a homology model of the hRyR2 N-terminal region, are presented. The N-terminus is held together by a unique network of interactions among its three domains, A, B and C, in which the central helix (amino acids 410-437) plays a prominent stabilizing role. Importantly, the anion-binding site reported for the mouse RyR2 N-terminal region is notably absent from the human RyR2. The structure concurs with the differential stability of arrhythmogenic mutations in the central helix (R420W, I419F and I419F/R420W) which are owing to disparities in the propensity of mutated residues to form energetically favourable or unfavourable contacts. In solution, the N-terminus adopts a globular shape with a prominent tail that is likely to involve residues 545-606, which are unresolved in the crystal structure. Docking the N-terminal domains into cryo-electron microscopy maps of the closed and open RyR1 conformations reveals C(α) atom movements of up to 8 Å upon channel gating, and predicts the location of the leucine-isoleucine zipper segment and the interaction site for spinophilin and phosphoprotein phosphatase 1 on the RyR surface.
Insights
The human ryanodine receptor 2 (hRyR2) N-terminus structure reveals key interactions stabilizing the protein. This finding explains arrhythmogenic mutations and identifies binding sites for regulatory proteins.
Area of Science:
- Cardiovascular Biology
- Molecular Biophysics
- Structural Biology
Background:
- The N-terminal region of human ryanodine receptor 2 (hRyR2) is crucial for cardiomyocyte contraction and is implicated in over 30 arrhythmogenic mutations.
- This region also serves as a binding site for phosphoprotein phosphatase 1, a key regulator of cardiac function.
Purpose of the Study:
- To determine the solution and crystal structures of the hRyR2 N-terminal region under near-physiological conditions.
- To elucidate the structural basis for arrhythmogenic mutations and identify regulatory interaction sites.
Main Methods:
- X-ray crystallography and solution structure determination of the hRyR2 N-terminal region (amino acids 1-606).
- Homology modeling and docking into cryo-electron microscopy maps of RyR1.
- Analysis of mutation stability based on residue interactions.
Main Results:
- The hRyR2 N-terminus adopts a globular structure stabilized by interactions among domains A, B, and C, with a central helix playing a key role.
- An anion-binding site present in mouse RyR2 is absent in the human ortholog.
- Arrhythmogenic mutations in the central helix show differential stability linked to altered residue contacts.
- Channel gating involves significant C(α) atom movements in the N-terminal domains.
Conclusions:
- The determined structure provides insights into the stability of the hRyR2 N-terminus and the mechanism of arrhythmogenic mutations.
- The findings predict the location of functional sites, including those for spinophilin and phosphoprotein phosphatase 1, on the RyR channel surface.
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Electrophysiology of Normal Cardiac Rhythm
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...

